Breast Cancer Screening in Ghana
Testing Approaches to Promote Breast Cancer Screening in Rural Ghana
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Yubraj Acharya, Ph.D.
- Phone Number: 8148656898
- Email: yua36@psu.edu
Study Locations
-
-
-
Accra, Ghana
- University of Ghana
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- ≥20 years. The age cutoff reflects early onset of BC in Ghana and the government's guidelines on screening.
Exclusion Criteria:
- ever clinically diagnosed with a case of breast cancer, as the study's aim is to reach women who would normally not visit or have experience with the health system with regard to breast cancer.
NOTE: For men in the MEGH arm, Inclusion and Exclusion Criteria are:
Inclusion Criteria: aged ≥20 years who are identified as male partners or relatives by the women enrolled in the MEGH group.
Exclusion Criteria: none.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
No Intervention: Control
Women in this arm receive education on breast cancer and are offered clinical breast exam free of charge at their local clinic for 6 months following the education session.
|
|
|
Experimental: Bundling
Women in this arm receive education on breast cancer, diabetes, and hypertension, and are offered clinical breast exam and screening for diabetes and hypertension free of charge at their local clinic for 6 months following the education session.
|
Education on and screening for diabetes and hypertension offered together with education and screening for breast cancer.
|
|
Experimental: Male Engagement in Gender and Health (MEGH)
Women in this arm receive education on breast cancer and are offered clinical breast exam free of charge at their local clinic for 6 months following the education session.
In addition, women are requested to invite their male partners to attend the breast cancer education session and 7 weekly discussion group sessions (5 men-only and 2 with women).
The discussion sessions aim to enable men to change gender attitudes and behaviors that deter women's healthcare utilization.
|
Education on breast cancer and discussion sessions to male partners to change men's gender attitudes and behaviors.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Clinical breast exam (CBE) utilization at the local clinic
Time Frame: 6 months. Outcome is measured at endline survey at the end of the 6-month period.
|
The outcome will be measured by asking participants, at endline, if they sought clinical breast exam at their local clinic during the 6-month study period.
This information will be verified at the clinic level using Participation Cards, which will be provided to participants at the beginning of the 6-month period.
Participants will be asked to bring the Card to the clinic when they come for screening.
|
6 months. Outcome is measured at endline survey at the end of the 6-month period.
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Study Chair: Nancy Luke, Ph.D., The Pennsylvania State University
- Study Chair: Adriana Biney, Ph.D., University of Ghana, Regional Institute for Population Studies
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- STUDY00021561
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.